Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the role of active deresuscitation after resuscitation-2 (RADAR-2) randomised clinical trial

Jonathan A. Silversides*, Ross McMullan, Lydia M. Emerson, Ian Bradbury, Jonathan Bannard-Smith, Tamas Szakmany, John Trinder, Anthony J. Rostron, Paul Johnston, Andrew J. Ferguson, Andrew J. Boyle, Bronagh Blackwood, John C. Marshall, Daniel F. McAuley

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

In the original article, there were some errors in the reporting of results: 1. The denominator for 180-day mortality was incorrectly calculated, leading to an erroneously high percentage mortality in both treatment arms being reported in Table 2 (Outcomes). 180-day mortality was reported as 25 (54.4%) for the intervention arm, and 21 (52.5%) for the usual care arm. The numerators are correct, but the relevant percentages are not, so that the correct numbers are 25 of 88 (28.4%) and 21 of 88 (23.9%) respectively. The associated P-value for this outcome should be 0.61 rather than 0.86. 2. The N in the left-hand column for the outcomes of anxiety, depression and PTSD is incorrect by 1. For anxiety N is reported as 34 when the correct number is 33; for depression we have reported 37 rather than 36, and for PTSD we have reported N = 35 when the correct number is 34. All significance testing was carried out using the correct data, so all reported P-values are correct. These errors do not affect the conclusions of the article. The authors apologize for the error. The original article has been corrected.

Original languageEnglish
Pages (from-to)1440
Number of pages1
JournalIntensive Care Medicine
Volume49
Early online date29 Aug 2023
DOIs
Publication statusPublished - Nov 2023

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the role of active deresuscitation after resuscitation-2 (RADAR-2) randomised clinical trial'. Together they form a unique fingerprint.

Cite this